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Magnesium deﬁciencyThe Ca2+-binding helix–loop–helix structural motif called “EF-hand” is a common building block of a large
family of proteins that function as intracellular Ca2+-receptors. These proteins respond speciﬁcally to
micromolar concentrations of Ca2+ in the presence of ~1000-fold excess of the chemically similar divalent
cation Mg2+. The intracellular free Mg2+ concentration is tightly controlled in a narrow range of 0.5–1.0 mM,
which at the resting Ca2+ levels is sufﬁcient to fully or partially saturate the Ca2+-binding sites of many EF-
hand proteins. Thus, to convey Ca2+ signals, EF-hand proteins must respond differently to Ca2+ than to Mg2+.
In this review the structural aspects of Mg2+ binding to EF-hand proteins are considered and interpreted in
light of the recently proposed two-step Ca2+-binding mechanism (Grabarek, Z., J. Mol. Biol., 2005, 346, 1351).
It is proposed that, due to stereochemical constraints imposed by the two-EF-hand domain structure, the
smaller Mg2+ ion cannot engage the ligands of an EF-hand in the same way as Ca2+ and defaults to stabilizing
the apo-like conformation of the EF-hand. It is proposed that Mg2+ plays an active role in the Ca2+-dependent
regulation of cellular processes by stabilizing the “off state” of some EF-hand proteins, thereby facilitating
switching off their respective target enzymes at the resting Ca2+ levels. Therefore, some pathological
conditions attributed toMg2+deﬁciencymight be related to excessive activation of underlying Ca2+-regulated
cellular processes. This article is part of a Special Issue entitled: 11th European Symposium on Calcium.es of Health (grant HL-91162).
1th European Symposium on
l rights reserved.© 2011 Elsevier B.V. All rights reserved.The EF-hand is a Ca2+-binding helix–loop–helix structural motif
discovered by R.H. Kretsinger in the X-ray structure of parvalbumin
[1]. It is a basic building unit of a large family of proteins that serve as
intracellular Ca2+-receptors. These proteins undergo conformational
changes upon binding Ca2+, which enables them to reversibly bind to
and regulate the activity of various target enzymes. Paradoxically,
parvalbumin, the ﬁrst crystallized member of this family, does not
change its structure signiﬁcantly on binding Ca2+ and appears to
contribute to Ca2+ signaling only indirectly by buffering the cytosolic
free Ca2+. Among the Ca2+-sensor proteins, troponin C (TnC) and
calmodulin (CaM), each consisting of four EF-hand motifs, have
served as models for extensive structure–function studies and our
current understanding of the EF-hand is based to a large extent on these
studies. The early work in the laboratory of the late Prof. Witold
Drabikowski at the Nencki Institute of Experimental Biology inWarsaw
has demonstrated that both TnC and CaM can be split by limited
proteolysis into two approximately equal-size fragments that retain
their structure and Ca2+-binding properties [2–7]. Thus, this work has
deﬁned a pair of EF-hand motifs as a structurally independent,functional domain. Subsequently, the high-resolution X-ray and NMR
structures of TnC [8–10] and CaM [11–14] provided a vivid demons-
tration of domain independence in these proteins, the functional
signiﬁcance ofwhichbecameapparentwhen the details of TnC andCaM
interactions with their target molecules were established [15–20].
A pair of EF-hand motifs forms a structurally stable cooperative
domain due to the network of hydrogen bonds that connect the
Ca2+-binding loops (a short stretch of antiparallel β-sheet) and due
to extensive hydrophobic contacts among the helices ﬂanking the
Ca2+-binding loops [21]. This EF-hand pairing pattern, ﬁrst deﬁned in
the structure of parvalbumin [1], has been reproduced in all high-
resolution structures of EF-hand proteins [22], and in model systems
utilizing synthetic peptide analogs of EF-hands [23–25]. The bond
network directly connecting the two Ca2+ ions in the domain,
collectively called “EF-hand β-scaffold”, plays an important role in the
Ca2+-binding mechanism and, in a recently proposed two-step
mechanism, it is viewed as critical for the Ca2+-induced conformational
transitions, and thus for theCa2+-signaling functionof EF-handproteins
[26,27]. An extensive discussion of the EF-hand proteins' structure and
function can be found in the recent review by Gifford et al. [28].
The focus of the present review is the speciﬁcity of the EF-hand
proteins, i.e., their ability to recognize Ca2+ signals in the cytosol in
the presence of ~1000-fold excess of the chemically similar divalent
cation Mg2+. This remarkable property is discussed in light of the EF-
hand-β-scaffold model [26,27], which implies that, due to speciﬁc
Fig. 1. The Ca2+-induced conformational change in site I of CaM. The structures of the
N-terminal domain of human recombinant CaM in the Ca2+-bound form (PDB ID: 1CLL
[112]) and apo form of rat recombinant CaM (PDB ID: 1QX5 [113]) have been
superimposed using the backbone atoms of the β-scaffold (see Ref. [27] for details). In
this conformation independent frame of reference the movement of the helices and
closing of the loop associated with Ca2+ coordination can be discerned. Note the large
shift of the C-terminal bidentate ligand (Glu31). This shift is enabled by the backbone
dihedral angle changes in the branched hydrophobic residues of the β-scaffold (Ile27 in
site I of CaM), which work as a hinge [26].
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same way as Ca2+ does. It is further proposed that Mg2+ may play an
active role in the Ca2+-dependent regulation of cellular processes by
stabilizing the off state of some EF-hand proteins, thereby facilitating
switching off their downstream activity at the resting Ca2+ levels.
Some pathological conditions attributed to Mg2+ deﬁciency might be
related to excessive activation of underlying Ca2+-regulated cellular
processes.
1. The EF-hand calcium switch
The mechanism of the Ca2+-induced conformational changes in
EF-hand proteins has been the subject of extensive studies for several
decades. Although numerous techniques have provided evidence for
the Ca2+-dependent structural changes in TnC, CaM and other EF-
hand proteins, the ﬁrst comprehensive description of the Ca2+ switch
came from Herzberg, Moult and James [29] on the basis of the crystal
structure of TnC [8,9]. The switch occurs in a two-EF-hand domain and
involves a change in the relative orientation of the helices ﬂanking the
Ca2+-binding loops, thus causing a transition from a “closed” to an
“open” domain conformation. This “off” to “on” transition leads to the
exposure of a hydrophobic pocket that serves as a target interaction
site (reviewed in Refs. [21,22,28]).
The HMJ-model provided a description of the Ca2+ switch but has
not explained the underlying mechanism. An important insight in this
respect came from the work of Sykes and colleagues who pointed to
the critical role of the invariant Glu residue in the 12th position of the
Ca2+-binding loop [30,31]. This residue contributes two oxygen atoms
of its γ-carboxyl group to the coordination sphere of the Ca2+ ion
(a bidentate ligand). The importance of this residue was also evident
from the earlier experiments on CaM showing that substitutions of
Glu12 with Gln or Lys in the four Ca2+-binding sites of CaM had
deleterious effects on the Ca2+-binding afﬁnity and target enzyme
activation [32–34]. More detailed information about the Ca2+-binding
mechanism came from the X-ray structure of a CaM mutant, which
had intact Ca2+-binding loops, but was lockedwith a disulﬁde bond in
the closed, apo-like, conformation [26]. In that structure, the Glu12
ligand was found at some distance from the Ca2+ ion, thus providing
evidence for direct coupling between that ligand and the movement
of the C-terminal (exiting) helix of an EF-hand and opening of the
domain. In that structure the relative position of the two Ca2+ ions
with respect to each other was found to be the same as in the open-
domain conformation. The inference from this observation was that
the structure connecting the two bound Ca2+, which includes the
invariant carbonyl oxygen ligand in the center of the loop (the −Y
metal coordinating position) and the short stretch of the β-sheet
connecting the two Ca2+-binding loops provide a stable, conforma-
tion-independent scaffold for Ca2+ binding [26]. Since each EF-hand
can bind Ca2+ only in the space very narrowly deﬁned by the
β-scaffold, the helices ﬂanking the Ca2+-binding loop have to move in
order for the other ligands to reach the metal ion (Fig. 1). This is
consistent with the requirement for pairing of the EF-hand motifs in a
domain. In a single EF-hand the Ca2+ ion would most likely affect the
local loop conformation without any long-range energetically unfa-
vorable helix movement. The proposed model referred to as the EF-
hand-β-scaffold model (EFBS) emphasizes the importance of the
structure connecting the two bound Ca2+ ions. The invariant
backbone carbonyl oxygen ligand in the center of the loop (cf.
Fig. 1) deﬁnes the position of the bound Ca2+ because unlike other
ligands it is virtually immobilized by the β-scaffold [26]. The hydrogen
bonds of the β-scaffold are highly polarized [35,36]; a property that
imparts the carbonyl −Y ligand with a partial negative charge, thus
further facilitating Ca2+ coordination. According to the EFBS model,
Ca2+ binding occurs in two steps. Initially the N-terminal ﬂexible part
of the Ca2+-binding loop coordinates the Ca2+ ion. In the next step,
bond rotation in the β-scaffold, speciﬁcally a change in the dihedralϕ,ψ angles of the residue in the 8th position of the loop, enables the
side chain of the Glu residue in the 12th position to approach the Ca2+
ion [26]. The interaction of that last bidentate ligand with Ca2+ closes
the Ca2+-binding loop and causes the exiting helix to move, which
results in domain opening.
There are still very few EF-hand proteins for which both the apo
and the Ca2+-bound high-resolution X-ray structures are available. It
is clear, however, that the large conformational changes characteristic
of TnC and CaM are neither unique, nor common to all EF-hand
proteins. In fact, there is a great variety of possible structural
responses to Ca2+ [22,27,28,37]. However, irrespective of the extent
of the Ca2+-induced hydrophobic site exposure, or other more subtle
structural changes, the bidentate Ca2+ coordination by the Glu
residue in the last position of the Ca2+-binding loop is preserved. A
comparison of the high-resolution X-ray structures of various EF-hand
proteins suggests also that a mechanism similar to that outlined by
the EFBS model may operate not only in the canonical EF-hands, i.e.,
those containing 12 amino acids in the Ca2+-binding loop, but also in
those that have 11, 13 or 14 amino acids in the loop [27]. In these
”unconventional” EF-hands variations in the amino acid sequence,
composition and ultimately conformation are limited to the N-
terminal part of the Ca2+-binding loop, while the β-scaffold structure
and the bidentate Ca2+-coordination by the C-terminal Glu are
preserved. While several facets of the EFBS model are hypothetical at
present and require experimental veriﬁcation, the model appears to
offer attractive possibilities for design of new experiments, which
might lead to a better understanding of the EF-hand proteins'
function.
2. Calcium signaling in the presence of magnesium
Mg2+ is one of the three physiologically relevant metal ions that
are known to bind to EF-hand proteins and to modulate their Ca2+-
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some members of the S100 protein family [38]. The binding site for
Zn2+ and Cu2+ is located at the interface between two S100
monomers, outside of the N-terminal Ca2+-binding loop, and involves
His and Asp or Cys side chains in a tetrahedral coordination geometry
[39,40]. Apparently, different preferences for ligands and different
coordination geometry effectively exclude Zn2+ and Cu2+ from
competing with Ca2+ for the EF-hand Ca2+-binding sites.
The intracellular free Ca2+ concentrations ﬂuctuate between
10−7 M at rest and 10−5 M during activation [41,42]. In contrast,
the free Mg2+ level is relatively constant and falls in a narrow range
of 0.5–1.0 mM in most cells [43]. Interestingly, hormonal stimula-
tion can induce large ﬂuxes of Mg2+ through the cell membrane,
which suggests that the total Mg2+ content in cells and, indirectly,
the free Mg2+ concentrations are tightly regulated [44,45]. Many
EF-hand Ca2+-binding sites have Mg2+ dissociation constants in
submillimolar range, thus can be expected to bind Mg2+ in the
absence of competing Ca2+. This observation alone implies that the
Mg2+-bound structure should be different from the Ca2+-bound
structure. One of the two structures must represent the activated
form of the protein (the on state) while the other must correspond
to the off state, otherwise, for those EF-hand proteins that bind Mg2+
with appreciable afﬁnity, no relaxation and therefore no Ca2+
signaling would be possible. Indeed, there is a large body of published
data documenting differences between Ca2+ and Mg2+ binding and
the resultant structural and functional effects for various EF-hand
proteins. Some relevant observations for CaM and TnC are reviewed
below and interpreted in light of the EF-hand-β-scaffold model in
anticipation of arriving at some more general conclusions potentially
applicable to other EF-hand proteins.
3. Mg2+ binding to calmodulin
Calmodulin is a ubiquitously expressed Ca2+-sensor protein
responsible for the regulation of many crucial cellular processes
[46]. Therefore, the Mg2+-binding properties of CaM have been the
subject of great interest. A number of early studies with the use of
diverse techniques provided evidence for Mg2+ binding to CaM and
for signiﬁcant structural differences between the Mg2+-bound and
the Ca2+-bund forms of this protein [7,47–53]. There are large
differences in the Mg2+-CaM binding constants reported by various
authors (~102–104 M−1); however, there is a consensus that Mg2+
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Fig. 2.Mg2+ does not induce domain opening in CaM and TnC. Fluorescence emission spectra
of CaM (left) or C-TnC, the C-terminal domain fragment of rabbit skeletal TnC, in the pres
excitation at 394 nm in solution containing 0.1 MNaCl, 20 mMHEPES pH 7.0. Note a large inc
the presence of MgCl2.site I in the N-terminal domain has the highest afﬁnity for Mg2+ [53–
56]. For example, Tsai et al. have reported Ka=3.5×103 M−1 for the
N-terminal domain and Ka=2–3×102 M−1 for the C-terminal
domain [53]. On the basis of their NMR studies, Malmendal et al.
have concluded that nearly half of the sites in the N-terminal domain
of CaM would be occupied by Mg2+ in resting eukaryotic cells [55].
They also suggested that Mg2+ binding might occur without ligation
to the residue in the 12th loop position, consequently causing smaller
structural changes. In another work from the same group, the
apparent afﬁnity for Ca2+ of the N-terminal domain of CaM was
found to be signiﬁcantly decreased at physiological Mg2+ levels,
consistent with a model in which each site can bind either Ca2+ or
Mg2+ [57]. Under speciﬁc conditions a signiﬁcant population of a
mixed Mg2+/Ca2+ state was found and the Ca2+ off-rate from this
state was at least one order of magnitude faster than from the 2Ca2+
state. The mixed state was found to have a conformation more similar
to the “closed” apo and 2Mg2+ states than to the “open” 2Ca2+ state
[57]. A more complex view of the Ca2+/Mg2+ competition emerged
from microcalorimetric studies [51,58–60]. Gilli et at. have found the
thermodynamic parameters of Mg2+ and Ca2+ binding to CaM
inconsistent with a simple competition mechanism and proposed
that Mg2+ is an allosteric effector with respect to Ca2+ binding and
that the four main Mg2+-binding sites are distinct from the EF-hand
Ca2+-binding sites [60]. In the absence of high-resolution X-ray
structure of Mg2+-bound CaM it is not clear what exactly the
distinction between the Mg2+- and Ca2+-binding sites might be.
Perhaps the two different views could be reconciled by a model in
which Mg2+ engages only a subset of the ligands that interact with
Ca2+ and, as a result, stabilizes domain conformation that is very
different from that induced by Ca2+.
There is evidence for a strong stabilization of both domains of CaM
in the presence of Ca2+ or Mg2+, as reﬂected in a large increase in the
unfolding temperature [61,62]. For each metal, however, the
stabilized conformation is different. Indeed, a simple test with a
hydrophobic ﬂuorescent probe bisANS can be used to demonstrate
that Mg2+ binding does not induce domain opening in CaM, whereas
Ca2+ does (Fig. 2, cf. also Ref. [50]). This highly speciﬁc effect of Ca2+ is
apparently attributable to the ionic radius of the metal ion, i.e., those
metals whose ionic radii are closest to Ca2+ (~1.0 Å) are able to
substitute for Ca2+ in the activation of CaM target enzymes [63]. The
ﬁnal point that needs to be considered with respect to the potential
Mg2+ effect on Ca2+-CaM signaling is the role of the target enzyme.

























of bisANS (4,4′-dianilino-1,1′-binaphthyl-5,5′-disulfonic acid) alone and after addition
ence of 1 mM CaCl2 or 10 mM MgCl2 and 0.5 mM EGTA were recorded at 20 °C upon
rease in ﬂuorescence of bisANS if the protein is added in the presence of CaCl2 but not in
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extent of the effect depends on the type of the target [54,56].
According to Martin et al., Mg2+ has a role in directing the mode of
initial target binding preferentially to the C-domain of CaM, due to the
opposite relative afﬁnities for binding of Ca2+ and Mg2+ to the two
domains. Thus, they concluded, Mg2+ ampliﬁes the intrinsic differ-
ences of the domains in a target-speciﬁc manner [56].4. Mg2+ binding to troponin C
In contrast to CaM, which has multiple targets and many
functions, troponin C is speciﬁcally expressed in striated muscles
where, as a part of the F-actin-bound regulatory troponin–
tropomyosin complex, it functions as a Ca2+-activated trigger of
muscle contraction [64–66]. Although TnC, like CaM, is comprised
of two independent domains, the difference in Ca2+ afﬁnity
between the domains is larger, which appears to provide a clear
deﬁnition of their function [5,67]. The lower afﬁnity sites in the
N-domain are considered Ca2+ speciﬁc and are directly involved in
the regulatory function of TnC. There are conﬂicting reports on the
effect of Mg2+ on the Ca2+ sensitivity of myoﬁbrils and
reconstituted thin ﬁlaments [67,68]. In more recent model studies
Mg2+ was found to compete with Ca2+ for the regulatory domain
of skeletal TnC with the apparent dissociation constant
Kd=2.2 mM [69]. The C-terminal domain contains the high-afﬁnity
Ca2+-binding sites that also bind Mg2+, thus are called the Ca2+/
Mg2+ sites and are believed to play a structural role by providing
stability to the troponin complex [67,70–72]. The potential role of
the Ca2+/Mg2+ sites in regulation of contraction was originally
rejected due to the slow kinetics of Mg2+ dissociation from these
sites (~8 s−1) which would be a rate-limiting step for Ca2+ binding
at these sites during activation [70]. The regulatory role of the
N-domain has been conﬁrmed by site directed mutagenesis [72,73];
however, various observations suggest that the Ca2+/Mg2+ sites
also contribute to the mechanism of regulation. For example, in a
reconstituted system the C-terminal domain fragment of TnC
retains partial regulatory activity [74–76]. There is evidence for a
Ca2+-dependent communication between the TnC domains in the
troponin complex [77] which most likely involves the interaction of
the inhibitory segment of troponin I (a twelve-residue stretch that
binds actin and inhibits actin-myosin ATPase) with helix E, the
N-terminal helix of the Ca2+/Mg2+ site III of TnC [20]. It is not clear if
that interaction is affected in any way by the Mg2+/Ca2+ exchange
at the adjacent site. The apparent equilibrium binding constant for
Mg2+binding to theC-domainof TnChas beenestimated at5×103 M−1
in free TnC and 5×104 M−1 in the troponin complex [67], which is
sufﬁciently high for these sites to be fully occupied by Mg2+ at the
resting Ca2+ concentrations. Due to slow Mg2+ dissociation rate little
Mg2+/Ca2+ exchange can be expected during a single activation–
relaxation cycle; however, full exchange can occur during prolonged or
repetitive contraction [70]. The C-domain of TnC has little structure in
the apo form; however, both Ca2+ and Mg2+ induce folding [5,78–80]
and strong stabilization of that domain [61,62]. Again, like for CaM, the
Mg2+-bound conformation of the C-domain of TnC is closed, while the
Ca2+-bound conformation is open (Fig. 2). The open conformation of
the C-domain of TnC, as detected by bisANS, is consistent with the
crystal structure of TnC [8,9] and is clearly required for the interaction of
this domain with the N-terminal α-helical segment of troponin I in the
presence of Ca2+ [19,20,81]. However, the closed conformation of that
domain in+Mg2+ state poses a problem, because it would require
dissociation (or a different type of interaction) of the troponin I
N-terminal segment. No such dissociation is evident in the currently
available low-resolution structure (7.0 Å) of the apo form of skeletal
troponin core domain [20]. Also the NMR studies of cardiac C-domain
complex with TnI peptide revealed a monodentate Mg2+ ligation bythe conserved Glu12 and partial closure of the hydrophobic binding
cleft around Ca2+-binding site IV [82]. These data might suggest that
the closed domain Mg2+-bound structure detected in solution is
sufﬁciently ﬂexible to open and accommodate the interacting TnI
helix. Alternatively, a high-resolution structure of a complete
regulatory complex may be required to reveal the effects of Mg2+/
Ca2+ exchange at this domain. In favor of the latter interpretation
are data on F1 isoform of TnC from stretch activated insect ﬂight
muscle, in which only site IV in the C-domain is functional, and
Ca2+ binding to that site is required for the function of this
protein [83–85].5. Structure of the Mg2+-bound EF-hand
Clearly, there is strong evidence for conformational differences
between the Ca2+ and Mg2+-bound forms of CaM and TnC.
Unfortunately these differences are difﬁcult to interpret in
structural terms because no X-ray structures of the Mg2+-bound
forms of these proteins are available. In fact, currently there are
only three X-ray crystallographic structures of the Mg2+-bound EF-
hand proteins in the Protein Data Bank: parvalbumin, calbindin
D9k (S100G, according to the recent update on nomenclature [86])
and the scallop myosin regulatory light chain (RLC). In the
structure of S100G, Mg2+ is bound to the C-terminal Ca2+-speciﬁc
EF-loop. The loop has extended conformation similar to that in the
apo form and Mg2+ interacts only with the N-terminal ligands of
the loop. The Glu12 is too far from the bound cation for its side
chain to contribute to Mg2+ coordination. Instead, a water
molecule is found at that position (PDB ID: 1IG5, [87], cf. Fig. 3).
The helices are more tightly packed than in the Ca2+-bound form.
Overall, the Mg2+-bound EF-hand conformation of S100G is highly
reminiscent of the Ca2+-bound EF-hands in the disulﬁde locked
CaM [26]. In the Mg2+-bound loop of parvalbumin (PDB ID: 4PAL,
[88], cf. Fig. 3) the side chain of Glu12 is rotated 120° to provide
only one oxygen ligand for Mg2+ coordination as compared to the
Ca2+-bound structure (PDB ID: 4CPV, [89], cf. Fig. 3). The EF-hand
conformation is essentially the same as that of the Ca2+-bound
form. The transition from bidentate Ca2+ coordination to mono-
dentate Mg2+ coordination by Glu12 is apparently related to the
difference in ionic radii (1.06 Å for Ca2+ vs. 0.72 Å for Mg2+ [90])
as demonstrated by molecular dynamics simulations [91]. These
structures point to two very distinctive features of the Mg2+-bound
vs. Ca2+-bound EF-hand conformations: (i) the geometry of the
Mg2+ coordination in both parvalbumin and S100G is octahedral,
even though the two proteins accomplish this geometry in
different ways. (ii) The bidentate interaction with the Glu12 side
chain, which is a deﬁning characteristic of the Ca2+ complex, is
absent in both Mg2+–protein complexes.
The Mg2+-bound structure of scallop myosin RLC (PDB ID: 1WDC
[92]) shows a different and less frequent variant of the EF-hand motif
featuring an Asp residue at position 12 instead of Glu. Paradoxically,
this substitution makes an EF-hand speciﬁc for Mg2+ [93], or perhaps
more aptly, the afﬁnity for Ca2+ decreases to the extent that it
becomes irrelevant in the physiological range of cellular free Ca2+
concentrations. The preference of the Mg2+ ion for a shorter side
chain (Asp) in the last position of the loop is somewhat counterin-
tuitive considering that the ionic radius of Mg2+ is ~30% smaller than
Ca2+. One might expect that an Asp containing loop would have to
compress signiﬁcantly more, thus causing a larger shift of the
exitinghelix, as compared to that featuringGlu in the last position. This
is not the case, however, since the Asp side chain only contributes a
single oxygen atom to the octahedral coordination of Mg2+, and
therefore does not signiﬁcantly constrain the loop conformation. The
bidentate coordination that is required for Ca2+ is apparently not
possible with the shorter Asp side chain. This subtle difference
Fig. 3. Geometry of the equatorial plane of Ca2+ and Mg2+ complexes with an EF-hand. A—Schematic representation of an idealized metal oxygen complex. The radius of the sphere
in the center (rMe) is related to the number (n) and the radius (rO) of the surrounding spheres by rO/(rMe+rO)=sin(360/2n). For rO=1.52 Å (van der Waals radius of the oxygen
atom) we obtain rMe=1.06 Å for n=5 and rMe=0.63 Å for n=4, which correlate well with the ionic radii for Ca2+ and Mg2+ obtained by X-ray crystallography (1.06 Å and 0.72 Å,
respectively [90]). Note that the relative orientation of the Glu12 ligand with respect to the invariant carbonyl oxygen of the EF-hand-β-scaffold (assigned here as number 1 at the
top) depends on the coordination number. The two oxygen atoms of the bidentate Glu12 ligand (atoms numbered 2 and 3) occupy adjacent positions in the equatorial plane of the
complex. This is the key feature of the complex that sets the direction of approach for the side chain of Glu12 and consequently the position of the exiting helix with respect to the β-
scaffold (approximately 108° as marked by the arrows). A similar bidentate coordination of Mg2+ by Glu12 would not be possible due to a larger angle of approach (135°) which
would require the exiting helix to move much farther away from the β-scaffold and possibly clash with the incoming helix. For the Ca2+ complex the O–Ca2+–O bond angle is 72°, as
compared to 90° for the Mg2+ complex. B—The EF-loop of carp parvalbumin in the Ca2+-bound form (PDB ID: 4CPV [89] beta isoform pI=4.25) and pike parvalbumin in Mg2+-
bound form (PDB ID: 4PAL [88] beta isoform pI=4.1) conformation. The equatorial plane of each complex is shown in a similar orientation as that in (A) with the carbonyl oxygen
ligand of the β-scaffold (the –Y coordinating position) at the top. The yellow and cyan spheres represent Ca2+ and Mg2+, respectively, and the red and magenta spheres are the
oxygen atoms in direct contact with the metal ion. The backbone atoms of the 12 amino acids comprising the Ca2+-binding loop are shown in stick representation. For clarity, side
chain atoms (in stick representation) are shown only for Glu12. The ionic radii were set to 1.06 Å for Ca2+ (sevenfold coordination) and 0.72 Å for Mg2+ (sixfold coordination)
according to Shannon [90]. For oxygen atoms the radius is set to 1.52 Å, which represents the van der Waals volume [114]. C—The C-terminal Ca2+-binding site of bovine
recombinant S100G (calbindin D9k) in the Ca2+-bound (PDB ID: 4ICB [115]) and Mg2+-bound (PDB ID: 1IG5 [87]) conformation. The pink sphere in the+Mg2+ structure is the
oxygen atom of a water molecule that substitutes for the Glu12 oxygen atoms, which are too far. These ﬁgures were generated with PyMol [116].
917Z. Grabarek / Biochimica et Biophysica Acta 1813 (2011) 913–921accounts for the reversed Mg2+/Ca2+ speciﬁcity of the RLC. Support
for this interpretation comes from the work of Phillips and
colleagues who have shown that substitution of Asp for Glu in
the EF loop of parvalbumin causes a 100-fold decrease in Ca2+afﬁnity, a 10-fold increase in Mg2+ afﬁnity, and that both
complexes adopt octahedral coordination [94].
The two Mg2+-EF-hand complexes shown in Fig. 3 represent
different domain structures in terms of the relative orientation of the
918 Z. Grabarek / Biochimica et Biophysica Acta 1813 (2011) 913–921helices ﬂanking the Ca2+-binding loop. The S100G–Mg2+ complex
resembles the closed domain, whereas the parvalbumin–Mg2+
complex is similar to the open domain conformation of CaM and
TnC. Unfortunately, neither S100G nor parvalbumin undergoes a large
structural change upon Ca2+ binding. Thus, it is not clear if the
conclusions based on these structures can be extrapolated to TnC, CaM
and other regulatory EF-hand proteins. In particular, we are left with
the following questions: (1) why is there a change from bidentate to
monodentate metal ion coordination by the carboxyl group in the
12th position? In principle, eliminating an oxygen ligand at any other
coordinating position of the loop could fulﬁll the Mg2+ requirement
for hexa-coordination. (2) What are the functional consequences of
the transition from bidentate to monodentate Glu12 interaction with
the metal ion?6. Interpretation of the Ca2+/Mg2+ speciﬁcity based on the
EF-hand-β-scaffold model
Differences in ionic radii, hydration and coordination geometry are
generally listed among those properties that enable EF-hand proteins
to discriminate between Ca2+ and Mg2+. The Mg2+ ion has ~30%
smaller ionic radius as compared to Ca2+. However, owing to the tight
ordering of water molecules the hydrated Mg2+ ion is approximately
400× larger in volume than its dehydrated form. In contrast, the
hydrated Ca2+ ion is only ~25× larger [95]. The difference in
hydration is important for ion transport [96] and for the kinetics of
binding to the EF-hand. The exchange rate of solvent water around the
hydrated Mg2+ is 3–4 orders of magnitude slower than for Ca2+ [95].
Thus, the Mg2+ binding on-rate is limited by the dehydration rate,
which accounts for the generally weak binding of Mg2+ to proteins
and small molecules. As discussed earlier, many EF-hand Ca2+-
binding sites have sufﬁciently high afﬁnity for Mg2+ to be partially or
fully saturated with Mg2+ at the resting Ca2+ concentrations. The key
factor for effective Ca2+ signaling is the difference in the resultant EF-
hand conformation, which in turn must be related to the ionic radius
and the coordination geometry of themetal ion. The EFBSmodel offers
a plausible explanation of the relation between these factors and why
Mg2+ is generally unable to substitute for Ca2+.
Fig. 3A illustrates the distribution of atoms in the equatorial plane
of an idealized metal ion–oxygen complex. The larger Ca2+ ion can
accommodate 5 oxygen atomswhereas only four oxygen atoms can ﬁt
in a plane around the smaller Mg2+. This difference can be
rationalized most simply in the following way: the radius of the
sphere in the center (rMe) is related to the number (n) and the radius
(rO) of the surrounding spheres by rO/(rMe+rO)=sin(360/2n). For
rO=1.52 Å (van der Waals radius of the oxygen atom) we obtain
rMe=1.06 Å for n=5 and rMe=0.63 Å for n=4, which correlate well
with the ionic radii for Ca2+ and Mg2+ obtained by X-ray
crystallography (1.06 Å and 0.72 Å, respectively [90]). Clearly, upon
substitution of Ca2+ with Mg2+ one of the oxygen ligands has to be
removed. There appear to be two reasons why it is the bidentate Glu12
ligand that is reduced to monodentate interaction.
The ﬁrst reason is related to the ﬁxed position of the carbonyl
oxygen ligand of the β-scaffold (assigned arbitrarily as number 1 in
Fig. 3A). The two oxygen atoms of the bidentate Glu12 ligand (atoms
numbered 2 and 3 in Fig. 3A) occupy adjacent positions in the
equatorial plane of the complex. This is the key feature of the complex
that sets the direction of approach for the side chain of Glu12 and
consequently the position of the exiting helix with respect to the
β-scaffold (approximately 108° as marked by the arrows). A similar
bidentate coordination of Mg2+ by Glu12 would not be possible
because it would require the exiting helix to move much farther away
from the β-scaffold (marked with a dashed arrow in Fig. 3A) and
possibly clash with the incoming helix. A change to a monodentate
interaction of Glu12 positions that residue at ~90° with respect to thecarbonyl oxygen ligand and also permits more ﬂexibility to the Glu12
side chain and ultimately to the exiting helix.
The second reason for the switch from bidentate for Ca2+ to
monodentate for Mg2+ Glu12–metal ion interaction may be related
to the difference in the Me–O bond lengths and, consequently,
Me–O–C bond angles. Analysis of the Ca2+–carboxylate interactions
in crystal structures of calcium complexes indicates a relatively broad
distribution of bond lengths (2.3–2.7 Å) and angles (110–170°) for
monodentate Ca2+–carboxylate interactions. In contrast, a bidentate
Ca2+–carboxylate interaction sets the Ca2+–O–C bond angle at 90°
[97]. Due to the smaller ionic radius, thus a shorter O–Me distance for
Mg2+ the Mg2+–O–C angle would have to be signiﬁcantly less than
90° for bidentate interaction, which apparently is unfavorable.
Analysis of high-resolution X-ray crystallographic structures of
small molecules containing carboxyl–metal ion complexes indicates
that bidentate interaction is virtually excluded for carboxyl–Mg2+
interaction. In contrast, Ca2+ frequently forms bidentate complexes
with carboxylates [98].
7. Functional implications
There are several ways in which Mg2+ may affect the function of
EF-hand proteins. The simplest effect is a decrease in the apparent
binding constant for Ca2+ due to Mg2+ competition for the binding
sites, which in turn will cause a shift of the target enzyme activation
curve to higher Ca2+ concentrations often referred to as a “decrease in
Ca2+ sensitivity”. The extent of the effect depends on the Mg2+
binding constant and the Mg2+ concentration according to the
relation: K′Ca=KCa/(1+KMg.[Mg2+ ]), where KCa and K′Ca are the
binding constants for Ca2+ in the absenceandpresenceofMg2+, andKMg
is the binding constant for Mg2+. This relation holds true for a single, or
independent site. In reality, the relation is likely to bemore complex due
to the fact that Ca2+ binds cooperatively to CaM, TnC and other EF-hand
proteins. Furthermore, there is evidence for negative allostery between
Mg2+ and Ca2+ [57,87], as reﬂected in the faster dissociation of Ca2+
from the mixed Ca2+/Mg2+ species. The problem of predicting Mg2+
effects is further compounded by the various preferences of the
interacting target molecules (e.g., Ref. [56]). In view of the data in
Fig. 2 and other published observations, Mg2+ clearly stabilizes the
closed domain conformation of CaM. This apparently is the preferred
conformation for the group of targets that utilize the so-called IQ domain
forCaMbinding [99]. Recent studiesbyPersechini andcolleagues suggest
a switchingmechanism inwhicheachdomainof CaMplays a speciﬁc and
different role in eachof its conformations [100]. It is likely thatMg2+may
further diversify the Ca2+ signaling in these proteins due to speciﬁc
modulation of the Ca2+ response of each domain [56]. Moreover, one
may expect rather complex responses for various EF-handprotein-target
systems in environments where Mg2+ concentrations change.
While it is important to consider the effects of Mg2+ on the EF-
hand target interaction in order to interpret the in vitro binding
parameters, the absolute effect of Mg2+ is perhaps of lesser
importance from the physiological point of view. The important
question is if small changes in intracellular Mg2+ concentrations
might be expected to alter in any physiologically relevant manner the
intracellular Ca2+ signaling. In other words how big an effect has to be
in order to be physiologically relevant? Candidates include systems
requiring very tight regulation of cellular responses. For example, in
familial hypertrophic cardiomyopathy a small (pCab0.1) increase in
Ca2+ sensitivity of TnC regulated actin ﬁlaments leads to diminished
quality of life and premature death [101]. Indeed, the function of the
heart is not only regulated directly by precise Ca2+ transients but also
modulated in many ways by diverse signaling pathways, some of
which are sensitive to Ca2+ [102]. Small effects at the many checking
points of this complex system caused by changes in Mg2+ concen-
tration may have a signiﬁcant cumulative effect on the function of the
heart. Other systems that seem likely to be affected by changingMg2+
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the CaM-kinase cascade [103], or the integrative systems that respond
to cumulative effects of multiple small Ca2+ transients.
The total magnesium concentration in mammalian cells is 15–
20mM, thus making Mg2+ the second most abundant cellular cation
after potassium. However, only a small fraction (~1 mM) of the total
Mg2+ in cells is in the form of free ion [95]. Mg2+ is a cofactor in many
intracellular processes by virtue of binding to ATP and other
nucleotides. It is also involved in the catalytic function of many
enzymes, contributes to the stability of proteins and mediates some
speciﬁc protein–protein interactions. The intracellular Mg2+ concen-
trations are hormonally regulated [45,104,105], suggesting that Mg2+
homeostasis is of vital importance. There is extensive literature
documenting a correlation between cellular or dietary Mg2+ deﬁciency
and a number of pathological conditions [106]. In particular, Mg2+
deﬁciency has been correlated with cardiovascular diseases including
heart attack, speciﬁc forms of cardiac arrhythmias, angina and
congestive heart failure, as well as hypertension, inﬂammation, asthma,
metabolic syndrome and many others [107–110]. In some studies the
protective effect of Mg2+ on cardiovascular system has been compared
favorably to those of statin pharmaceuticals [111]. Although the
important role of intracellular Mg2+ is recognized, the underlying
biochemical and molecular mechanisms are not well understood.
8. Conclusion
The structural analysis presented in this review indicates that Mg2+
and Ca2+ have opposing effects on the structure and function of
calmodulin, troponin C and related EF-hand Ca2+-binding proteins.
Therefore Mg2+ may be an important factor in modulating the Ca2+
sensitivity and, in particular, switchingoff someCa2+-regulated systems
at the resting cellular Ca2+ levels. Although at this point it would be
premature to make any speciﬁc connections, it is likely that some
pathological conditions attributed to Mg2+ deﬁciency are related to
excessive activation of underlying Ca2+-regulated cellular processes.
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